Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders

Carmen García-Ibarbia, Jesus Delgado-Calle, Iñigo Casafont, Javier Velasco, Jana Arozamena, María I. Pérez-Núñez, María A. Alonso, María T. Berciano, Fernando Ortiz, José L. Pérez-Castrillón, Agustín F. Fernández, Mario F. Fraga, María T. Zarrabeitia, José A. Riancho

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We reported previously that the expression of Wnt-related genes is lower in osteoporotic hip fractures than in osteoarthritis. We aimed to confirm those results by analyzing β-catenin levels and explored potential genetic and epigenetic mechanisms involved.β-Catenin gene expression and nuclear levels were analyzed by real time PCR and confocal immunofluorescence. Increased nuclear β-catenin was found in osteoblasts isolated from patients with osteoarthritis (99. ±. 4 units vs. 76. ±. 12, p. = 0.01, n. = 10), without differences in gene transcription, which is consistent with a post-translational down-regulation of β-catenin and decreased Wnt pathway activity.Twenty four single nucleotide polymorphisms (SNPs) of genes showing differential expression between fractures and osteoarthritis (WNT4, WNT10A, WNT16 and SFRP1) were analyzed in DNA isolated from blood of 853 patients. The genotypic frequencies were similar in both groups of patients, with no significant differences.Methylation of Wnt pathway genes was analyzed in bone tissue samples (15 with fractures and 15 with osteoarthritis) by interrogating a CpG-based methylation array. Six genes showed significant methylation differences between both groups of patients: FZD10, TBL1X, CSNK1E, WNT8A, CSNK1A1L and SFRP4. The DNA demethylating agent 5-deoxycytidine up-regulated 8 genes, including FZD10, in an osteoblast-like cell line, whereas it down-regulated other 16 genes.In conclusion, Wnt activity is reduced in patients with hip fractures, in comparison with those with osteoarthritis. It does not appear to be related to differences in the allele frequencies of the Wnt genes studied. On the other hand, methylation differences between both groups could contribute to explain the differences in Wnt activity.

Original languageEnglish (US)
Pages (from-to)165-172
Number of pages8
JournalGene
Volume532
Issue number2
DOIs
StatePublished - Dec 15 2013
Externally publishedYes

Fingerprint

Wnt Signaling Pathway
Epigenomics
Catenins
Osteoarthritis
Methylation
Genes
Hip Fractures
Osteoblasts
Deoxycytidine
Osteoporotic Fractures
DNA
Gene Frequency
Single Nucleotide Polymorphism
Fluorescent Antibody Technique
Real-Time Polymerase Chain Reaction
Down-Regulation
Gene Expression
Bone and Bones
Cell Line

Keywords

  • β-Catenin
  • Bone diseases
  • DNA methylation
  • Fractures
  • Wnt

ASJC Scopus subject areas

  • Genetics

Cite this

García-Ibarbia, C., Delgado-Calle, J., Casafont, I., Velasco, J., Arozamena, J., Pérez-Núñez, M. I., ... Riancho, J. A. (2013). Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders. Gene, 532(2), 165-172. https://doi.org/10.1016/j.gene.2013.09.080

Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders. / García-Ibarbia, Carmen; Delgado-Calle, Jesus; Casafont, Iñigo; Velasco, Javier; Arozamena, Jana; Pérez-Núñez, María I.; Alonso, María A.; Berciano, María T.; Ortiz, Fernando; Pérez-Castrillón, José L.; Fernández, Agustín F.; Fraga, Mario F.; Zarrabeitia, María T.; Riancho, José A.

In: Gene, Vol. 532, No. 2, 15.12.2013, p. 165-172.

Research output: Contribution to journalArticle

García-Ibarbia, C, Delgado-Calle, J, Casafont, I, Velasco, J, Arozamena, J, Pérez-Núñez, MI, Alonso, MA, Berciano, MT, Ortiz, F, Pérez-Castrillón, JL, Fernández, AF, Fraga, MF, Zarrabeitia, MT & Riancho, JA 2013, 'Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders', Gene, vol. 532, no. 2, pp. 165-172. https://doi.org/10.1016/j.gene.2013.09.080
García-Ibarbia C, Delgado-Calle J, Casafont I, Velasco J, Arozamena J, Pérez-Núñez MI et al. Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders. Gene. 2013 Dec 15;532(2):165-172. https://doi.org/10.1016/j.gene.2013.09.080
García-Ibarbia, Carmen ; Delgado-Calle, Jesus ; Casafont, Iñigo ; Velasco, Javier ; Arozamena, Jana ; Pérez-Núñez, María I. ; Alonso, María A. ; Berciano, María T. ; Ortiz, Fernando ; Pérez-Castrillón, José L. ; Fernández, Agustín F. ; Fraga, Mario F. ; Zarrabeitia, María T. ; Riancho, José A. / Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders. In: Gene. 2013 ; Vol. 532, No. 2. pp. 165-172.
@article{c8045886447443e5a5413560c8cab72b,
title = "Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders",
abstract = "We reported previously that the expression of Wnt-related genes is lower in osteoporotic hip fractures than in osteoarthritis. We aimed to confirm those results by analyzing β-catenin levels and explored potential genetic and epigenetic mechanisms involved.β-Catenin gene expression and nuclear levels were analyzed by real time PCR and confocal immunofluorescence. Increased nuclear β-catenin was found in osteoblasts isolated from patients with osteoarthritis (99. ±. 4 units vs. 76. ±. 12, p. = 0.01, n. = 10), without differences in gene transcription, which is consistent with a post-translational down-regulation of β-catenin and decreased Wnt pathway activity.Twenty four single nucleotide polymorphisms (SNPs) of genes showing differential expression between fractures and osteoarthritis (WNT4, WNT10A, WNT16 and SFRP1) were analyzed in DNA isolated from blood of 853 patients. The genotypic frequencies were similar in both groups of patients, with no significant differences.Methylation of Wnt pathway genes was analyzed in bone tissue samples (15 with fractures and 15 with osteoarthritis) by interrogating a CpG-based methylation array. Six genes showed significant methylation differences between both groups of patients: FZD10, TBL1X, CSNK1E, WNT8A, CSNK1A1L and SFRP4. The DNA demethylating agent 5-deoxycytidine up-regulated 8 genes, including FZD10, in an osteoblast-like cell line, whereas it down-regulated other 16 genes.In conclusion, Wnt activity is reduced in patients with hip fractures, in comparison with those with osteoarthritis. It does not appear to be related to differences in the allele frequencies of the Wnt genes studied. On the other hand, methylation differences between both groups could contribute to explain the differences in Wnt activity.",
keywords = "β-Catenin, Bone diseases, DNA methylation, Fractures, Wnt",
author = "Carmen Garc{\'i}a-Ibarbia and Jesus Delgado-Calle and I{\~n}igo Casafont and Javier Velasco and Jana Arozamena and P{\'e}rez-N{\'u}{\~n}ez, {Mar{\'i}a I.} and Alonso, {Mar{\'i}a A.} and Berciano, {Mar{\'i}a T.} and Fernando Ortiz and P{\'e}rez-Castrill{\'o}n, {Jos{\'e} L.} and Fern{\'a}ndez, {Agust{\'i}n F.} and Fraga, {Mario F.} and Zarrabeitia, {Mar{\'i}a T.} and Riancho, {Jos{\'e} A.}",
year = "2013",
month = "12",
day = "15",
doi = "10.1016/j.gene.2013.09.080",
language = "English (US)",
volume = "532",
pages = "165--172",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders

AU - García-Ibarbia, Carmen

AU - Delgado-Calle, Jesus

AU - Casafont, Iñigo

AU - Velasco, Javier

AU - Arozamena, Jana

AU - Pérez-Núñez, María I.

AU - Alonso, María A.

AU - Berciano, María T.

AU - Ortiz, Fernando

AU - Pérez-Castrillón, José L.

AU - Fernández, Agustín F.

AU - Fraga, Mario F.

AU - Zarrabeitia, María T.

AU - Riancho, José A.

PY - 2013/12/15

Y1 - 2013/12/15

N2 - We reported previously that the expression of Wnt-related genes is lower in osteoporotic hip fractures than in osteoarthritis. We aimed to confirm those results by analyzing β-catenin levels and explored potential genetic and epigenetic mechanisms involved.β-Catenin gene expression and nuclear levels were analyzed by real time PCR and confocal immunofluorescence. Increased nuclear β-catenin was found in osteoblasts isolated from patients with osteoarthritis (99. ±. 4 units vs. 76. ±. 12, p. = 0.01, n. = 10), without differences in gene transcription, which is consistent with a post-translational down-regulation of β-catenin and decreased Wnt pathway activity.Twenty four single nucleotide polymorphisms (SNPs) of genes showing differential expression between fractures and osteoarthritis (WNT4, WNT10A, WNT16 and SFRP1) were analyzed in DNA isolated from blood of 853 patients. The genotypic frequencies were similar in both groups of patients, with no significant differences.Methylation of Wnt pathway genes was analyzed in bone tissue samples (15 with fractures and 15 with osteoarthritis) by interrogating a CpG-based methylation array. Six genes showed significant methylation differences between both groups of patients: FZD10, TBL1X, CSNK1E, WNT8A, CSNK1A1L and SFRP4. The DNA demethylating agent 5-deoxycytidine up-regulated 8 genes, including FZD10, in an osteoblast-like cell line, whereas it down-regulated other 16 genes.In conclusion, Wnt activity is reduced in patients with hip fractures, in comparison with those with osteoarthritis. It does not appear to be related to differences in the allele frequencies of the Wnt genes studied. On the other hand, methylation differences between both groups could contribute to explain the differences in Wnt activity.

AB - We reported previously that the expression of Wnt-related genes is lower in osteoporotic hip fractures than in osteoarthritis. We aimed to confirm those results by analyzing β-catenin levels and explored potential genetic and epigenetic mechanisms involved.β-Catenin gene expression and nuclear levels were analyzed by real time PCR and confocal immunofluorescence. Increased nuclear β-catenin was found in osteoblasts isolated from patients with osteoarthritis (99. ±. 4 units vs. 76. ±. 12, p. = 0.01, n. = 10), without differences in gene transcription, which is consistent with a post-translational down-regulation of β-catenin and decreased Wnt pathway activity.Twenty four single nucleotide polymorphisms (SNPs) of genes showing differential expression between fractures and osteoarthritis (WNT4, WNT10A, WNT16 and SFRP1) were analyzed in DNA isolated from blood of 853 patients. The genotypic frequencies were similar in both groups of patients, with no significant differences.Methylation of Wnt pathway genes was analyzed in bone tissue samples (15 with fractures and 15 with osteoarthritis) by interrogating a CpG-based methylation array. Six genes showed significant methylation differences between both groups of patients: FZD10, TBL1X, CSNK1E, WNT8A, CSNK1A1L and SFRP4. The DNA demethylating agent 5-deoxycytidine up-regulated 8 genes, including FZD10, in an osteoblast-like cell line, whereas it down-regulated other 16 genes.In conclusion, Wnt activity is reduced in patients with hip fractures, in comparison with those with osteoarthritis. It does not appear to be related to differences in the allele frequencies of the Wnt genes studied. On the other hand, methylation differences between both groups could contribute to explain the differences in Wnt activity.

KW - β-Catenin

KW - Bone diseases

KW - DNA methylation

KW - Fractures

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=84886752108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886752108&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2013.09.080

DO - 10.1016/j.gene.2013.09.080

M3 - Article

C2 - 24096177

AN - SCOPUS:84886752108

VL - 532

SP - 165

EP - 172

JO - Gene

JF - Gene

SN - 0378-1119

IS - 2

ER -